• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SCARBOROUGH INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO; IVD FOR HIV AG/AB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SCARBOROUGH INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO; IVD FOR HIV AG/AB Back to Search Results
Catalog Number 7D2648
Device Problem False Positive Result (1227)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Information (3190)
Event Date 11/20/2018
Event Type  malfunction  
Manufacturer Narrative
No kit, lot number was provided for a specific investigation.No sample was returned for further testing, and no additional information was provided.A review of complaint trends revealed that all of the alere determine hiv ½ ag/ab lots are performing according to label claims.The exact root cause of the reported issue could not be determined.The results obtained may possibly be related to the patient sample.The sample may have contained specific substances which may have affected the results.The available evidence suggests that the device is performing within labeled claims.
 
Event Description
A customer reported two (b)(6) results with the alere determine hiv 1/2 ag/ab combo.There is insufficient information to determine if a malfunction occurred.The exact number of patient or patients was not reported.The patient(s) gender, pregnancy status, treatment and patient outcome were unknown.No device lot number was provided.Attempts to gain additional patient information were not successful.
 
Event Description
(b)(6)2018 : additional information.Both patients were reported as male.The alere determine hiv 1/2 ag/ab combo test results were both positive for ag.The confirmatory negative testing was performed with an hiv 4th generation test.
 
Manufacturer Narrative
Risk of short- and medium-term toxicity to a non-pregnant female patient with the current recommended art prophylaxis regimens is primarily transient metabolic abnormalities which appears to be primarily mild and reversible after treatment is interrupted.The risk will not cause or contribute to a death or serious injury and is therefore considered not reportable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE DETERMINE HIV 1/2 AG/AB COMBO
Type of Device
IVD FOR HIV AG/AB
Manufacturer (Section D)
ALERE SCARBOROUGH INC.
10 southgate road
scarborough ME 04074
MDR Report Key8077327
MDR Text Key127367313
Report Number1221359-2018-00547
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
PMA/PMN Number
BP120037-0
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 11/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number7D2648
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/25/2018
Initial Date FDA Received11/16/2018
Supplement Dates Manufacturer Received10/25/2018
Supplement Dates FDA Received11/21/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-